These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 24560399

  • 1. Insufficiency of electrocardiogram alone in predicting infrahisian abnormalities in patients with type 1 myotonic dystrophy.
    Siméon E, Patier-Dussauge A, Bernard-Brunet A, Clémenty N, Gouraud JB, Guyomarch B, Magot A, Probst V, Babuty D.
    Int J Cardiol; 2014 Apr 01; 172(3):625-7. PubMed ID: 24560399
    [No Abstract] [Full Text] [Related]

  • 2. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
    Groh WJ, Groh MR, Saha C, Kincaid JC, Simmons Z, Ciafaloni E, Pourmand R, Otten RF, Bhakta D, Nair GV, Marashdeh MM, Zipes DP, Pascuzzi RM.
    N Engl J Med; 2008 Jun 19; 358(25):2688-97. PubMed ID: 18565861
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Progressive conduction disturbance in myotonic dystrophy.
    Palazzolo J, Trucco E, Arce M, Riera AR, Femenía F.
    Cardiol J; 2011 Jun 19; 18(3):322-5. PubMed ID: 21660927
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P, Audoubert M, Cintas P, Rollin A, Duparc A, Mondoly P, Chiriac AM, Acket B, Zhao X, Pasquié JL, Cardin C, Delay M, Sadron M, Carrié D, Galinier M, Davy JM, Arne-Bès MC, Raczka F.
    Heart Rhythm; 2014 Oct 19; 11(10):1721-7. PubMed ID: 25016148
    [Abstract] [Full Text] [Related]

  • 6. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH, Tarnopolsky MA, Bergstra TG, Nair GM, Al-Qubbany A, Healey JS.
    Pacing Clin Electrophysiol; 2012 Oct 19; 35(10):1262-9. PubMed ID: 22385162
    [Abstract] [Full Text] [Related]

  • 7. The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications.
    Lallemand B, Clementy N, Bernard-Brunet A, Pierre B, Corcia P, Fauchier L, Raynaud M, Pellieux S, Babuty D.
    Heart; 2012 Feb 19; 98(4):291-6. PubMed ID: 22038543
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.
    Breton R, Mathieu J.
    Can J Cardiol; 2009 Feb 19; 25(2):e23-7. PubMed ID: 19214296
    [Abstract] [Full Text] [Related]

  • 9. The heart and cardiac pacing in Steinert disease.
    Nigro G, Papa AA, Politano L.
    Acta Myol; 2012 Oct 19; 31(2):110-6. PubMed ID: 23097601
    [Abstract] [Full Text] [Related]

  • 10. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
    Dello Russo A, Mangiola F, Della Bella P, Nigro G, Melacini P, Bongiorni MG, Tondo C, Calò L, Messano L, Pace M, Pelargonio G, Casella M, Sanna T, Silvestri G, Modoni A, Zachara E, Moltrasio M, Morandi L, Nigro G, Politano L, Palladino A, Bellocci F.
    J Cardiovasc Med (Hagerstown); 2009 Jan 19; 10(1):51-8. PubMed ID: 19708226
    [Abstract] [Full Text] [Related]

  • 11. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.
    Magrì D, Piccirillo G, Bucci E, Pignatelli G, Cauti FM, Morino S, Latino P, Santini D, Marrara F, Volpe M, Antonini G, Testa M.
    Int J Cardiol; 2012 May 03; 156(3):259-64. PubMed ID: 21112106
    [Abstract] [Full Text] [Related]

  • 12. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
    Wahbi K, Babuty D, Probst V, Wissocque L, Labombarda F, Porcher R, Bécane HM, Lazarus A, Béhin A, Laforêt P, Stojkovic T, Clementy N, Dussauge AP, Gourraud JB, Pereon Y, Lacour A, Chapon F, Milliez P, Klug D, Eymard B, Duboc D.
    Eur Heart J; 2017 Mar 07; 38(10):751-758. PubMed ID: 27941019
    [Abstract] [Full Text] [Related]

  • 13. Relation of CTG expansion and clinical variables to electrocardiogram conduction abnormalities and sudden death in patients with myotonic dystrophy.
    Sabovic M, Medica I, Logar N, Mandić E, Zidar J, Peterlin B.
    Neuromuscul Disord; 2003 Dec 07; 13(10):822-6. PubMed ID: 14678805
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up.
    Vio R, Zorzi A, Bello L, Bozzoni V, Botta A, Rivezzi F, Leoni L, Migliore F, Bertaglia E, Iliceto S, Pegoraro E, Corrado D, Calore C.
    Heart Rhythm; 2020 Nov 07; 17(11):1944-1950. PubMed ID: 32525073
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K, Algalarrondo V, Bécane HM, Fressart V, Beldjord C, Azibi K, Lazarus A, Berber N, Radvanyi-Hoffman H, Stojkovic T, Béhin A, Laforêt P, Eymard B, Hatem S, Duboc D.
    Arch Cardiovasc Dis; 2013 Dec 07; 106(12):635-43. PubMed ID: 24140416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.